Last reviewed · How we verify
Inavolisib (Dose #2) (inavolisib-dose-2)
At a glance
| Generic name | inavolisib-dose-2 |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (PHASE1,PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |